• Exosomal Egr2 Modulates Neuronal Injury via RNF8/DAPK1 in St

  2026-04-22

  This study uncovers a novel mechanism by which bone marrow-derived mesenchymal stem cell (BMSC) exosomal Egr2 confers neuroprotection in ischemic stroke. By elucidating the Egr2–RNF8–DAPK1 signaling axis, the research provides new insight into exosome-mediated neuronal survival pathways and potential therapeutic targets.

• Haloprogin: Translational Leverage in Antifungal Innovation

  2026-04-22

  This thought-leadership article explores the mechanistic underpinnings and translational potential of Haloprogin (1,2,4-trichloro-5-((3-iodoprop-2-yn-1-yl)oxy)benzene) as a broad-spectrum topical antimicrobial agent. Integrating evidence from foundational studies and contemporary workflows, we provide actionable guidance for researchers tackling dermatophytosis, Candida albicans, and Gram-positive bacterial infections. Distinct from standard product pages, this piece bridges mechanistic insight with strategic experimental design, protocol optimization, and clinical translation.

• Acridine Orange hydrochloride: Technical Guide for Nucleic A

  2026-04-21

  Acridine Orange hydrochloride enables selective, dual-fluorescence staining of DNA and RNA, offering reliable discrimination in cell cycle analysis, apoptosis detection, and flow cytofluorometric nucleic acid assays. Use is recommended for cytochemical workflows requiring specific and robust nucleic acid visualization; not suitable where long-term solution stability or non-nucleic acid targets are required.

• HRP Goat Anti-Rabbit IgG (H+L) Antibody: Protocol and QC Gui

  2026-04-21

  The HRP Goat Anti-Rabbit IgG (H+L) Antibody is designed for sensitive detection and signal amplification of rabbit primary antibodies in immunoassays such as Western blot, ELISA, and IHC. Researchers benefit from its affinity purification and HRP conjugation, which support robust and reproducible workflows. This reagent is not intended for diagnostic or clinical applications and should not be substituted for in vivo or therapeutic use.

• Adipose-Neural Axis Drives EAT-Linked Cardiac Arrhythmias

  2026-04-20

  Fan et al. (2024) reveal that epicardial adipose tissue (EAT) interacts with sympathetic neurons via leptin and neuropeptide Y (NPY), promoting arrhythmogenesis. Their stem cell-based coculture model elucidates mechanistic links and highlights potential therapeutic targets for cardiac arrhythmia intervention.

• Eltanexor (KPT-8602): Redefining Nuclear Export in Cancer Re

  2026-04-20

  Eltanexor (KPT-8602) is a second-generation, orally bioavailable XPO1 inhibitor with proven efficacy across a spectrum of hematological and solid tumor models. This article provides a mechanistic deep dive into XPO1-mediated nuclear export, integrates recent evidence linking Eltanexor to modulation of the Wnt/β-catenin pathway in colorectal cancer, and delivers strategic guidance for translational researchers. By contextualizing Eltanexor’s unique profile—superior tolerability, hematopoietic stem cell sparing, and robust activity—against the competitive landscape, we outline how researchers can optimally leverage this agent in next-generation experimental designs and chemoprevention models. This thought-leadership piece surpasses conventional product summaries, charting a forward-looking roadmap for innovation in cancer therapeutics targeting nuclear export.

• Beclin1 Deficiency Reduces DOX-Induced Liver Ferroptosis and

  2026-04-19

  This study demonstrates that Beclin1 deficiency alleviates doxorubicin-induced liver injury by inhibiting ferroptosis and autophagy. Findings highlight Beclin1 and DHODH as key therapeutic targets in oxidative liver damage, with direct implications for biomarker-driven research.

• Biotin Azide: Precision Biotinylation for Click Chemistry Wo

  2026-04-18

  Biotin Azide is transforming the specificity and versatility of bio-orthogonal labeling for alkynylated biomolecules. This article details how to leverage N-(3-azidopropyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide in advanced affinity purification, detection, and interaction studies—grounded in robust protocols and troubleshooting insights.

• Toremifene Citrate: Oral SERM Benchmarks for Breast Cancer R

  2026-04-17

  Toremifene Citrate is a potent oral selective estrogen receptor modulator (SERM) widely used in breast cancer and endocrinology research. Its high affinity for ERα and ERβ, robust in vitro and in vivo benchmarks, and clear clinical pharmacokinetics make it a gold-standard tool for dissecting estrogen receptor signaling and hormone receptor modulation.

• Protoporphyrin IX: Precision Tools for Ferroptosis and Oncol

  2026-04-16

  This thought-leadership article explores Protoporphyrin IX as a pivotal photodynamic compound at the interface of heme biosynthesis, iron metabolism, and cancer therapy. By integrating mechanistic insights, recent ferroptosis research, and strategic guidance for translational scientists, we articulate how leveraging high-purity Protoporphyrin IX (APExBIO) enables advanced modeling of disease processes and therapeutic innovation. We contrast current protocols, highlight emerging frontiers, and provide actionable parameters for experimental design.

• AICAR and AMPK: Decoding Macrophage Polarization in Inflamma

  2026-04-15

  Explore how AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) advances our understanding of AMPK-driven macrophage polarization and inflammation inhibition. This in-depth analysis reveals novel insights for metabolic disease research and practical guidance for assay design.

• Phenothiazines Boost Macrophage Antibacterial Function via R

  2026-04-14

  This study demonstrates that phenothiazines, including dopamine D2 receptor inhibitors, enhance the antibacterial activity of macrophages by inducing reactive oxygen species (ROS) production and autophagy. The findings highlight a promising host-directed therapeutic strategy against intracellular bacterial infections, with practical implications for translational research in immunology and neuropharmacology.

• Selective Nanomolar IRAP Inhibitors via α-Hydroxy-β-Amino Be

  2026-04-13

  This study introduces a diastereo- and regioselective synthetic route to α-hydroxy-β-amino acid derivatives of bestatin, producing the first highly selective, low-nanomolar inhibitors of insulin-regulated aminopeptidase (IRAP). Structural analysis reveals key determinants of potency and selectivity, providing a robust foundation for next-generation peptide-based inhibitor design.

• Palonosetron Hydrochloride: Advancing Selective 5-HT3 Antago

  2026-04-13

  This review highlights the key pharmacological and clinical advancements of palonosetron hydrochloride as a highly selective 5-HT3 receptor antagonist for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting. The study demonstrates palonosetron’s unique receptor selectivity, prolonged half-life, and superior efficacy for delayed emesis, with direct implications for translational and clinical research.

• SMAD3 Inhibition Reduces ADAMTS-5 in Early Osteoarthritis: I

  2026-04-12

  Xiang et al. demonstrate that targeted inhibition of SMAD3, a pivotal mediator in the TGF-β signaling pathway, leads to significant downregulation of the cartilage-degrading enzyme ADAMTS-5 during early osteoarthritis. The study highlights a mechanistic link via miRNA-140, offering new directions for fibrosis and cartilage degeneration research.

15566 records 1/1038 page Next 12345 下5页 Last page